Pharmacoeconomics in the era of individualized medicine

被引：13

作者：

Waldman, S. A. ^{[1
]}

Terzic, A. ^{[2
,3
,4
,5
,6
]}

机构：

[1] Thomas Jefferson Univ, Dept Med, Div Clin Pharmacol, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA

[2] Mayo Clin, Div Cardiovasc Dis, Dept Med, Rochester, MN USA

[3] Mayo Clin, Div Cardiovasc Dis, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA

[4] Mayo Clin, Div Cardiovasc Dis, Dept Med Genet, Rochester, MN USA

[5] Mayo Clin, Div Clin Pharmacol, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA

[6] Mayo Clin, Div Clin Pharmacol, Dept Med, Rochester, MN USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 84卷 / 02期

关键词：

D O I：

10.1038/clpt.2008.142

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：179 / 182

页数：4

共 15 条

[1] Metabolic syndrome: From global epidemiology to individualized medicine [J].

Batsis, J. A. ;

Nieto-Martinez, R. E. ;

Lopez-Jimenez, F. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (05) :509-524

[2] A vision of individualized medicine in the context of global health [J].

Cortese, D. A. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (05) :491-493

[3] Using pharmacoeconomics to value pharmacotherapy [J].

Hay, J. W. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (02) :197-200

[4] Personalized medicine: Elusive dream or imminent reality? [J].

Lesko, L. J. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (06) :807-816

[5] Paving the critical path: How can clinical pharmacology help achieve the vision? [J].

Lesko, L. J. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) :170-177

[6] The art and science of personalized medicine [J].

Piquette-Miller, M. ;

Grant, D. M. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) :311-315

[7] Pharmacoeconomics is coming of age [J].

Pizzi, L. T. ;

Singh, V. P. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (02) :188-190

[8] The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace [J].

Sollano, J. A. ;

Kirsch, J. M. ;

Bala, M. V. ;

Chambers, M. G. ;

Harpole, L. H. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (02) :263-266

[9] Biornarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs [J].

Wagner, J. A. ;

Williams, S. A. ;

Webster, C. J. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (01) :104-107

[10] Therapeutic targeting: A crucible for individualized medicine [J].

Waldman, S. A. ;

Terzic, A. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (05) :651-654

← 1 2 →